Stepwise synthesis of oligonucleotide-peptide conjugates containing guanidinium and lipophilic groups in their 3′-termini

被引:12
作者
Grijalvo, Santiago
Terrazas, Montserrat
Avino, Anna
Eritja, Ramon [1 ]
机构
[1] CSIC, Spanish Res Council, Inst Res Biomed IRB Barcelona, Networking Ctr Bioengn Biomat & Nanomed CIBER BBN, E-08028 Barcelona, Spain
关键词
ODN-peptide conjugates; Dickerson-Drew dodecamer; Luciferase; Postsynthetic guanidinylation reaction; Ureas; Antisense oligonucleotide; Phosphorothioates; SOLID-PHASE SYNTHESIS; ANTISENSE OLIGONUCLEOTIDES; CELLULAR UPTAKE; DRUG-DELIVERY; GENE; SEQUENCES; EFFICIENT; HYBRIDIZATION; BINDING; UREAS;
D O I
10.1016/j.bmcl.2010.02.049
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Two different series of oligonucleotide-peptide conjugates have been efficiently synthesized by stepwise solid-phase synthesis. First, oligonucleotides and oligonucleotide phosphorothioates containing polar groups at the 3'-termini, such as amine and guanidinium groups were prepared. ODNs conjugates carrying several lysine residues were obtained directly from Fmoc deprotection whereas ODN conjugates with guanidinium groups were obtained by post-synthetic guanidinylation. The second family contains different urea moieties that were achieved by standard protocols. All products were fully characterized by reversed phase HPLC and MALDI-TOF mass spectrometry yielding satisfactory results. Oligonucleotide-phosphorothioate conjugates were evaluated as potential antisense oligonucleotides in the inhibition of the luciferase gene. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2144 / 2147
页数:4
相关论文
共 39 条
  • [1] The delivery of antisense therapeutics
    Akhtar, S
    Hughes, MD
    Khan, A
    Bibby, M
    Hussain, M
    Nawaz, Q
    Double, J
    Sayyed, P
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2000, 44 (01) : 3 - 21
  • [2] New antibacterial agents derived from the DNA gyrase inhibitor cyclothialidine
    Angehrn, P
    Buchmann, S
    Funk, C
    Goetschi, E
    Gmuender, H
    Hebeisen, P
    Kostrewa, D
    Link, H
    Luebbers, T
    Masciadri, R
    Nielsen, J
    Reindl, P
    Ricklin, F
    Schmitt-Hoffmann, A
    Theil, FP
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (06) : 1487 - 1513
  • [3] Conjugates of antisense oligonucleotides with the Tat and antennapedia cell-penetrating peptides: Effects on cellular uptake, binding to target sequences, and biologic actions
    Astriab-Fisher, A
    Sergueev, D
    Fisher, M
    Shaw, BR
    Juliano, RL
    [J]. PHARMACEUTICAL RESEARCH, 2002, 19 (06) : 744 - 754
  • [4] Synthesis and Hybridization Properties of Modified Oligodeoxynucleotides Carrying Non-Natural Bases
    Avino, Anna
    Perez-Rentero, Sonia
    Garibotti, Alejandra V.
    Siddiqui, Maqbool A.
    Marquez, Victor E.
    Eritja, Ramon
    [J]. CHEMISTRY & BIODIVERSITY, 2009, 6 (02) : 117 - 126
  • [5] Stepwise synthesis of RNA conjugates carrying peptide sequences for RNA interference studies
    Avino, Anna
    Ocampo, Sandra M.
    Caminal, Clara
    Carlos Perales, Jose
    Eritja, Ramon
    [J]. MOLECULAR DIVERSITY, 2009, 13 (03) : 287 - 293
  • [6] THE SYNTHESIS OF MODIFIED OLIGONUCLEOTIDES BY THE PHOSPHORAMIDITE APPROACH AND THEIR APPLICATIONS
    BEAUCAGE, SL
    IYER, RP
    [J]. TETRAHEDRON, 1993, 49 (28) : 6123 - 6194
  • [7] Chemical modification of gene silencing oligonucleotides for drug discovery and development
    Chen, XL
    Dudgeon, N
    Shen, L
    Wang, JH
    [J]. DRUG DISCOVERY TODAY, 2005, 10 (08) : 587 - 593
  • [8] Solid phase urea synthesis: An efficient and direct conversion of Fmoc-protected amines to ureas
    Chong, PY
    Petillo, PA
    [J]. TETRAHEDRON LETTERS, 1999, 40 (24) : 4501 - 4504
  • [9] Recent advances in cell-penetrating, non-peptide molecular carriers
    Chung, Sung-Kee
    Maiti, Kaustabh K.
    Lee, Woo Sirl
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 354 (1-2) : 16 - 22
  • [10] Progress in antisense technology
    Crooke, ST
    [J]. ANNUAL REVIEW OF MEDICINE, 2004, 55 : 61 - 95